Modern Hematology — a Complex Interdisciplinary Tool

István Benedek 1  and Theodora Benedek 1
  • 1 University of Medicine and Pharmacy, , Tîrgu Mureș, Romania

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Benedek T, Kovács I, Benedek I. Therapeutic Angiogenesis for Severely Ischemic Limbs — from Bench to Bedside in Acute Vascular Care. Journal of Cardiovascular Emergencies. 2017;3:160-171.

  • 2. Tatu RF, Hurmuz M, Miu CA. ACL Primary Repair with Bone Marrow Stimulation and Growth Factors. A Review of Literature. Journal of Interdisciplinary Medicine. 2017; 2(S3):8-11.

  • 3. Ojeh N, Pastar I, Tomic-Canic M, Stojadinovic O. Stem Cells in Skin Regeneration, Wound Healing, and Their Clinical Applications. Int J Mol Sci. 2015;16:25476-25501.

  • 4. Hodonsky C, Mundada L, Wang S, et al. Effects of Scaffold Material Used in Cardiovascular Surgery on Mesenchymal Stem Cells and Cardiac Progenitor Cells. Ann Thorac Surg. 2015;99:605-611.

  • 5. Mester A, Mitre A, Lazar E, et al. Anemia and Iron Deficiency in Heart Failure – Clinical Update. Journal of Interdisciplinary Medicine. 2017;2:308-311.

  • 6. Shah R, Agarwal AK. Anemia associated with chronic heart failure: current concepts. Clin Interv Aging. 2013;8:111-122.

  • 7. Baysal E, Çetin M, Yaylak B, et al. Roles of the red cell distribution width and neutrophil/lymphocyte ratio in predicting thrombolysis failure in patients with an ST-segment elevation myocardial infarction. Blood Coagul Fibrinolysis. 2015;26:274-278.

  • 8. Karakas MS, Korucuk N, Tosun V, et al. Red cell distribution width and neutrophil-to-lymphocyte ratio predict left ventricular dysfunction in acute anterior ST-segment elevation myocardial infarction. J Saudi Heart Assoc. 2016;28:152-158.

  • 9. Pereg D, Berlin T, Mosseri M. Mean platelet volume on admission correlates with impaired response to thrombolysis in patients with STelevation myocardial infarction. Platelets. 2010;21:117-121.

  • 10. Chu SG, Becker RC, Berger PB, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost. 2010;8:148-156.

  • 11. Wagdy S, Sobhy M, Loutfi M. Neutrophil/Lymphocyte Ratio as a Predictor of In-Hospital Major Adverse Cardiac Events, New-Onset Atrial Fibrillation, and No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction. Clin Med Insights Cardiol. 2016;10:19-22.

  • 12. Bzduch A, Biro S, Sandor-Keri J, Benedek I Jr, Lazar E, Benedek I. Prognosis of patients with acute myeloid leukemia regarding the presence FLT3 gene mutation. Journal of Interdisciplinary Medicine. 2017;2:42-44.

  • 13. Hübel K, de la Rubbia J, Azar N, et al. Current status of haematopoietic autologous stem cell transplantation in lymphoid malignancies: a European perspective. Eur J Haematol. 2015;94:12-22.

  • 14. Pakucs A, Lazar E, Köpeczi JB, et al. Post autologous stem cell transplantation complication management in case of malignant lymphoma patients. Journal of Interdisciplinary Medicine. 2017;2:36-38.

  • 15. Mild E, Lazar E, Köpeczi JB, et al. Stem cell mobilization and harvesting failure in case of heavily pretreated patients. Journal of Interdisciplinary Medicine. 2017;2:39-41.

  • 16. Steffel J, Luscher TF, Tanner FC. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation. 2006;113:722-731.

  • 17. Nattel S, Harada M. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. J Am Coll Cardiol. 2014;63:2335-2345.

  • 18. Oltean P, Korodi S, Benedek I Jr, et al. Imaging-derived biomarkers associated with atrial FIBROsis, Structural remodeling and the risk of cardio-embolic events in patients with atrial fibrillation – the FIBROS study. Journal of Interdisciplinary Medicine. 2017;2:31-35.

  • 19. Tudor C, Lazar E, Gazdac M, et al. The evolution of intracardiac hemodynamics post autologous stem cell transplant in a case of multiple myeloma associated with severe tricuspid and mitral valve insufficiency. Journal of Interdisciplinary Medicine. 2017;2:45-47.

  • 20. Opincariu D, Mester A, Benedek I, Benedek I. Stem cell therapies in peripheral vascular diseases – current status. Journal of Interdisciplinary Medicine. 2017;2:12-19.

  • 21. Rigato M, Monami M, Fadini GP. Autologous Cell Therapy for Peripheral Arterial Disease: Systematic Review and Meta-Analysis of Randomized, Nonrandomized, and Noncontrolled Studies. Circ Res. 2017;120:1326-1340.

  • 22. Eirin A, Zhu XY, Krier JD, et al. Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis. Stem Cells. 2012;30:1030-1041.

  • 23. Jiang H, Qu L, Li Y, et al. Bone marrow mesenchymal stem cells reduce intestinal ischemia/reperfusion injuries in rats. J Surg Res. 2011;168:127-134.

  • 24. Mester A, Opincariu D, Benedek I, Benedek I. Stem cell therapy in wound healing. Journal of Interdisciplinary Medicine. 2017;2:20-24.

  • 25. Hassan WU, Greiser U, Wang W. Role of adipose-derived stem cells in wound healing. Wound Repair Regen. 2014;22:313-325.

  • 26. Procházka V, Gumulec J, Jalůvka F, et al. Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer. Cell Transplant. 2010;19:1413-1424.

  • 27. Haubner F, Ohmann E, Pohl F, et al. Wound healing after radiation therapy: review of the literature. Radiat Oncol. 2012;7:162.

  • 28. Maxson S, Lopez EA, Yoo D, Danilkovitch-Miagkova A, Leroux MA. Concise review: role of mesenchymal stem cells in wound repair. Stem Cells Transl Med. 2012;1:142-149.


Journal + Issues